The Australian National University (ANU) and ACT Government today announced a Memorandum of Understanding with the Peter MacCallum Cancer Centre (Peter Mac) to amplify Australia's research and clinical efforts to tackle cancer.
ANU Acting Vice-Chancellor Professor Mike Calford said it was a privilege for ANU to work with one of most eminent cancer research institutions in the world.
"The Peter MacCallum Centre is a world-leading cancer research organisation," Professor Calford said.
"I am confident the partnership between ANU, Peter Mac and ACT Government will deliver life-changing results for cancer patients and their families.
"This MoU will lead to collaboration and innovation in research addressing the needs of cancer patients and alleviate their suffering.
"ANU is very proud to be partnering with Peter Mac and the ACT Government on this important initiative."
The MoU includes establishing a research laboratory at ANU and Clinical Cancer Fellowships, increasing clinical trial capabilities and cancer genomics analysis at Canberra Hospital.
The MoU was signed by ACT Minister for Health & Wellbeing Meegan Fitzharris, ANU Acting Vice-Chancellor Professor Mike Calford and Peter Mac's Board Chair Maxine Morand at ANU Chancelry on Friday 14 September at 4:30pm.
Peter Mac was also represented at the signing by Executive Director Cancer Research Professor Ricky Johnstone, Chief Medical Officer David Speakman and Associate Director Laboratory Research Professor Rick Pearson.
"This will deliver new resources, skill-share and accelerated development opportunities for ACT-based cancer researchers while broadening the pipeline of exciting research underway at Peter Mac," says Professor Johnstone.
"Also importantly, it will expand access to clinical trials and genomics services for ACT-based cancer patients ensuring more can benefit from cutting-edge treatments and personalised medicine.
"Peter Mac thanks ANU and the ACT Government for sharing this vision and we look forward to a successful partnership."